Abstrakt
Background: Evidence is conflicting regarding statin use and risk of basal cell (BCC) and squamous cell skin cancer (SCC). Methods: Using Danish nationwide registries, we identified all patients with incident BCC/SCC during 2005-2009 and matched them to population controls. We computed odds ratios (ORs) for BCC and SCC associated with statin use. Results: We identified 38 484 cases of BCC and 3724 cases of SCC. Statin ever use was associated with ORs of 1.09 (CI: 1.06-1.13) for BCC and 1.01 (CI: 0.91-1.11) for SCC. Conclusions: Statin use was not associated with risk of SCC. Residual confounding plausibly explains the marginally increased risk of BCC.
Originalsprog | Engelsk |
---|---|
Tidsskrift | British Journal of Cancer |
Vol/bind | 112 |
Udgave nummer | 1 |
Sider (fra-til) | 153-156 |
ISSN | 0007-0920 |
DOI | |
Status | Udgivet - 6. jan. 2015 |